The India injection devices market size was estimated at USD 312.0 million 2025, and is expected to reach USD 869.5 million by 2035, growing at a CAGR of 10.9% from 2026 to 2035. The growth is driven by the country’s expanding healthcare infrastructure, rising disease burden, and increasing adoption of advanced drug delivery systems.
Injection devices, such as syringes, pen injectors, auto-injectors, and safety needles, are widely used in hospitals, clinics, and homecare settings to administer vaccines, insulin, biologics, and emergency medicines. With a large and growing population, India continues to demand safe, efficient, and cost-effective injection solutions. One of the major growth factors is the rising prevalence of chronic diseases, particularly diabetes. According to a BBC article published in June 2023, approximately 100 million people in India are living with diabetes, making it one of the largest diabetic populations in the world. This has significantly increased the demand for insulin delivery devices such as pen injectors and disposable syringes. The growing shift toward self-administration and home-based care is further accelerating the adoption of user-friendly injection devices.
Another key factor supporting market growth is the government’s strong focus on immunization programs. Initiatives such as the Universal Immunization Programme have significantly increased the use of disposable syringes across the country. Expanding the use of injectable therapies across applications such as diabetes care, autoimmune diseases, obesity, pain management, hormonal & metabolic therapies, and oncology has consistently driven demand for safe and efficient injection devices. The increasing focus on safety and infection control is also driving the adoption of advanced injection devices. The use of safety-engineered injection devices is gaining traction to reduce needle-stick injuries and prevent reuse. The World Health Organization has recommended the transition to safety syringes for all injections, and India has been gradually aligning with these guidelines through policy support and awareness initiatives. This shift is expected to create long-term demand for technologically advanced injection devices.
A major factor supporting the growth of the India injection devices industry is the rapid expansion of domestic manufacturing capacity for injection devices. Manufacturers are increasingly investing in advanced production technologies, automation, and capacity enhancement to meet the rising demand from hospitals, vaccination programs, and homecare settings. This growth is further supported by government initiatives such as the Production Linked Incentive (PLI) scheme for medical devices, which aims to boost local manufacturing and reduce dependence on imports. In addition, policy efforts promoting “Make in India” and strengthening healthcare infrastructure are encouraging both domestic and international players to establish or expand manufacturing facilities in the country. As a result, India is steadily emerging as a key hub for cost-effective and high-volume production of injection devices, supporting both domestic consumption and export opportunities.
The high and recurring demand for injection devices in India’s healthcare system reflects the extensive use across hospitals, clinics, and vaccination programs. This high procedural volume ensures consistent demand for injection devices, particularly disposable and safety syringes. At the same time, the growing focus on healthcare worker safety and infection prevention is accelerating the adoption of advanced injection devices. The notable prevalence of needle-stick injuries among healthcare professionals in India has raised concerns regarding the transmission of infections such as hepatitis and HIV. Consequently, there is increasing demand for safety-engineered syringes, prompting manufacturers to invest in safer, cost-effective, and technologically advanced injection solutions suited to the needs of the healthcare system.
Overall, the India injection devices market is poised for continued expansion, supported by rising healthcare needs, government initiatives, increasing chronic disease burden, and advancements in drug delivery technologies. With ongoing improvements in manufacturing capacity, regulatory support, and patient awareness, the market is expected to evolve toward safer, more efficient, and patient-centric injection devices in the forecast period
This product will be delivered within 1-3 business days.
Injection devices, such as syringes, pen injectors, auto-injectors, and safety needles, are widely used in hospitals, clinics, and homecare settings to administer vaccines, insulin, biologics, and emergency medicines. With a large and growing population, India continues to demand safe, efficient, and cost-effective injection solutions. One of the major growth factors is the rising prevalence of chronic diseases, particularly diabetes. According to a BBC article published in June 2023, approximately 100 million people in India are living with diabetes, making it one of the largest diabetic populations in the world. This has significantly increased the demand for insulin delivery devices such as pen injectors and disposable syringes. The growing shift toward self-administration and home-based care is further accelerating the adoption of user-friendly injection devices.
Another key factor supporting market growth is the government’s strong focus on immunization programs. Initiatives such as the Universal Immunization Programme have significantly increased the use of disposable syringes across the country. Expanding the use of injectable therapies across applications such as diabetes care, autoimmune diseases, obesity, pain management, hormonal & metabolic therapies, and oncology has consistently driven demand for safe and efficient injection devices. The increasing focus on safety and infection control is also driving the adoption of advanced injection devices. The use of safety-engineered injection devices is gaining traction to reduce needle-stick injuries and prevent reuse. The World Health Organization has recommended the transition to safety syringes for all injections, and India has been gradually aligning with these guidelines through policy support and awareness initiatives. This shift is expected to create long-term demand for technologically advanced injection devices.
A major factor supporting the growth of the India injection devices industry is the rapid expansion of domestic manufacturing capacity for injection devices. Manufacturers are increasingly investing in advanced production technologies, automation, and capacity enhancement to meet the rising demand from hospitals, vaccination programs, and homecare settings. This growth is further supported by government initiatives such as the Production Linked Incentive (PLI) scheme for medical devices, which aims to boost local manufacturing and reduce dependence on imports. In addition, policy efforts promoting “Make in India” and strengthening healthcare infrastructure are encouraging both domestic and international players to establish or expand manufacturing facilities in the country. As a result, India is steadily emerging as a key hub for cost-effective and high-volume production of injection devices, supporting both domestic consumption and export opportunities.
The high and recurring demand for injection devices in India’s healthcare system reflects the extensive use across hospitals, clinics, and vaccination programs. This high procedural volume ensures consistent demand for injection devices, particularly disposable and safety syringes. At the same time, the growing focus on healthcare worker safety and infection prevention is accelerating the adoption of advanced injection devices. The notable prevalence of needle-stick injuries among healthcare professionals in India has raised concerns regarding the transmission of infections such as hepatitis and HIV. Consequently, there is increasing demand for safety-engineered syringes, prompting manufacturers to invest in safer, cost-effective, and technologically advanced injection solutions suited to the needs of the healthcare system.
Overall, the India injection devices market is poised for continued expansion, supported by rising healthcare needs, government initiatives, increasing chronic disease burden, and advancements in drug delivery technologies. With ongoing improvements in manufacturing capacity, regulatory support, and patient awareness, the market is expected to evolve toward safer, more efficient, and patient-centric injection devices in the forecast period
India Injection Devices Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends in each sub-segment from 2021 to 2035. For this study, the analyst has segmented the India injection devices market report based on product and application:Product Outlook (Revenue, USD Unit, 2021-2035)
- Injector Pens
- Autoinjectors
- Injection Pumps
- Wearable Injectors/On-body Injectors
Application Outlook (Revenue, USD Unit, 2021-2035)
- Diabetes Care
- Autoimmune Diseases
- Oncology
- Hormonal & Metabolic Therapies
- Pain Management
- Obesity
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. India Injection Devices Market Variables, Trends & Scope
Chapter 4. India Injection Devices Market: Product Estimates & Trend Analysis
Chapter 5. India Injection Devices Market: Application Estimates & Trend Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Shaily Engineering Plastics Ltd
- Mediscient Devices Pvt. Ltd
- Otex Lifesciences Pvt. Ltd.
- BPL Medical Technologies
- AKAS Infusions
- Plenum Tech Private Limited.
- SMC Ltd
- Haselmeier India Private Limited
- Becton Dickinson (BD) India
- ARAYMOND LIFE
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | March 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 312 Million |
| Forecasted Market Value ( USD | $ 869.5 Million |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | India |
| No. of Companies Mentioned | 10 |
